Frank Casey

Prof. Frank Casey


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2016 in Cells
Verified
Journal Article
Open access
PDF file
KHKarim Harhouri
Karim Harhouri
CNClaire Navarro
Claire Navarro
CBCamille Baquerre
Camille Baquerre
NSNathalie Da Silva
Nathalie Da Silva
CBCatherine Bartoli
Catherine Bartoli
ASAnnachiara De Sandre-Giovannoli
Annachiara De Sandre-Giovannoli
Progeroid laminopathies, including Hutchinson-Gilford Progeria Syndrome (HGPS, OMIM #176670), are premature and accelerated aging diseases caused by defects in nuclear A-type Lamins. Most HGPS patients carry a de novo point mutation within exon 11 of the LMNA gene encoding A-type Lamins. This mutation activates a cryptic splice site leading to the deletion of 50 amino acids at its carboxy-terminal domain, resulting in a truncated and permanently farnesylated Prelamin A called Prelamin A Δ50 or Progerin. Some patients carry other LMNA mutations affecting exon 11 splicing and are named “HGPS-like” patients. They also produce Progerin and/or other truncated Prelamin A isoforms (Δ35 and Δ90) at the transcriptional and/or protein level. The results we present show that morpholino antisense oligonucleotides (AON) prevent pathogenic LMNA splicing, markedly reducing the accumulation of Progerin and/or other truncated Prelamin A isoforms (Prelamin A Δ35, Prelamin A Δ90) in HGPS-like patients’ cells. Finally, a patient affected with Mandibuloacral Dysplasia type B (MAD-B, carrying a homozygous mutation in ZMPSTE24, encoding an enzyme involved in Prelamin A maturation, leading to accumulation of wild type farnesylated Prelamin A), was also included in this study. These results provide preclinical proof of principle for the use of a personalized antisense approach in HGPS-like and MAD-B patients, who may therefore be eligible for inclusion in a therapeutic trial based on this approach, together with classical HGPS patients.

2 June 2010 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
FCFrank Casey
Frank Casey
MSM. Stewart
M. Stewart
CMC. G. McCusker
C. G. McCusker
MMM. L. Morrison
M. L. Morrison
BMB. Molloy
B. Molloy
HMH. C. Mulholland
H. C. Mulholland
Objectives: To assess the general health and activity levels of 4- and 5-year-old children after intervention for congenital cardiac disease. Methods: Health behaviour outcomes were assessed in 91 children who had surgery or catheter intervention for congenital cardiac disease. The children were classified into four groups according to severity. The main parameters of classification were the presence of residual symptoms, frequency of visits to general practitioner or the Accident and Emergency Department, and ability to participate in physical activity according to a calculated “activity score”. Results: Children had very few residual symptoms after “corrective surgery”. Those with complex congenital cardiac disease post-Fontan-type repair still had symptoms on average 18.2 days per month. Surprisingly, the complex group had fewer days “sick” from non-cardiac causes and had fewer visits to general practitioner or Accident and Emergency Departments. Regression analysis indicates that three variables had significant relevance to the general practitioner or Accident and Emergency visits: complex congenital cardiac disease, fewer visits; Townsend score – more deprivation – more visits; and maternal worry – higher maternal worry score – more visits. Regression analysis indicates that lower activity score is significantly related to complex cardiac disease and higher maternal worry score. Conclusions: The majority of this group of 4- and 5-year-old children had few residual symptoms and had good exercise tolerance. Maternal worry is a significant factor in influencing both activity levels and frequency of unscheduled health service demands – general practitioner or Accident and Emergency visits.

10 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
KHKarim Harhouri
Karim Harhouri
PCPierre Cau
Pierre Cau
FCFrank Casey
Frank Casey
KGKoffi Mawuse Guedenon
Koffi Mawuse Guedenon
YDYassamine Doubaj
Yassamine Doubaj
NLNicolas Levy
Nicolas Levy
Progeroid syndromes (PS), including Hutchinson-Gilford Progeria Syndrome (HGPS), are premature and accelerated aging diseases, characterized by clinical features mimicking physiological aging. Most classical HGPS patients carry a de novo point mutation within exon 11 of the LMNA gene encoding A-type lamins. This mutation activates a cryptic splice site, leading to the production of a truncated prelamin A, called prelamin A ∆50 or progerin, that accumulates in HGPS cell nuclei and is a hallmark of the disease. Some patients with PS carry other LMNA mutations and are named “HGPS-like” patients. They produce progerin and/or other truncated prelamin A isoforms (∆35 and ∆90). We previously found that MG132, a proteasome inhibitor, induced progerin clearance in classical HGPS through autophagy activation and splicing regulation. Here, we show that MG132 induces aberrant prelamin A clearance and improves cellular phenotypes in HGPS-like patients’ cells other than those previously described in classical HGPS. These results provide preclinical proof of principle for the use of a promising class of molecules toward a potential therapy for children with HGPS-like or classical HGPS.

22 August 2025 in Journal of Reproductive and Infant Psychology
Verified
Journal Article
Open access
CQCatherine Quinn
Catherine Quinn
SMSharon Millen
Sharon Millen
MDMartin Dempster
Martin Dempster
NDNicola Doherty
Nicola Doherty
FCFrank Casey
Frank Casey
Antenatal diagnoses of foetal abnormalities are associated with significant psychological distress for parents. This scoping review aims to identify and synthesise the existing literature on antenatally delivered psychological interventions for parents designed to support mental wellbeing following a foetal abnormality diagnosis. A prospectively registered protocol guided this scoping review, utilising methodologies outlined by Arksey and O'Malley (2005) and Levac et al. (2010). A systematic search was conducted using five electronic databases (PsycINFO, CINAHL, Medline, SCOPUS and ProQuest) with no date limits, including studies up to June 2024. Data was extracted following the Template for Intervention Description and Replication (TIDieR) checklist and synthesised using narrative synthesis. Twelve articles were included, addressing congenital heart defects (n = 6), chromosomal disorders (n = 2), foetal surgical anomalies (n = 2), cleft lip (n = 1) and congenital abnormalities (n = 1). Interventions incorporated approaches such as cognitive behavioural therapy, acceptance and commitment therapy, mindfulness and counselling. Individual support was the predominant approach across studies. All interventions were hospital-based, delivered by healthcare professionals, including psychologists, nurses and cardiologists, with formats ranging from single sessions to multi-session programmes. Most targeted anxiety and depressive symptoms, while some addressed stress, emotional preparedness, and decision-making. Antenatally delivered psychological interventions are emerging, but the evidence base remains limited. Future interventions should be tailored to meet individual needs, offer flexible delivery, and encourage multidisciplinary collaboration. Additionally, addressing both individual and systemic factors should be prioritised in the development of future interventions, as this may enhance feasibility, reach and impact.

30 October 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
ALAminkeng Zawuo Leke
Aminkeng Zawuo Leke
LDLionel Landry Sop Deffo
Lionel Landry Sop Deffo
YWYunkavi Sabastian Wirsiy
Yunkavi Sabastian Wirsiy
TAThomas James Aldersley
Thomas James Aldersley
TDThomas Day
Thomas Day
HDHelen Dolk
Helen Dolk
Background: Sub-Saharan Africa (SSA) bears the highest global burden of under-5 mortality, with congenital heart disease (CHD) as a major contributor. Despite advancements in high-income countries, CHD-related mortality in SSA remains largely unchanged due to limited diagnostic capacity and centralized health care. While pulse oximetry aids early detection, confirmation typically relies on echocardiography, a procedure constrained by a shortage of specialized personnel. Artificial intelligence (AI) offers a promising solution to bridge this diagnostic gap. Objective: This study aims to develop an AI-assisted echocardiography system that enables nonexpert operators, such as nurses, midwives, and medical doctors, to perform basic cardiac ultrasound sweeps on neonates suspected of CHD and extract accurate cardiac images for remote interpretation by a pediatric cardiologist. Methods: The study will use a 2-phase approach to develop a deep learning model for real-time cardiac view detection in neonatal echocardiography, utilizing data from St. Padre Pio Hospital in Cameroon and the Red Cross War Memorial Children’s Hospital in South Africa to ensure demographic diversity. In phase 1, the model will be pretrained on retrospective data from nearly 500 neonates (0-28 days old). Phase 2 will fine-tune the model using prospective data from 1000 neonates, which include background elements absent in the retrospective dataset, enabling adaptation to local clinical environments. The datasets will consist of short and continuous echocardiographic video clips covering 10 standard cardiac views, as defined by the American Society of Echocardiography. The model architecture will leverage convolutional neural networks and convolutional long short-term memory layers, inspired by the interleaved visual memory framework, which integrates fast and slow feature extractors via a shared temporal memory mechanism. Video preprocessing, annotation with predefined cardiac view codes using Labelbox, and training with TensorFlow and PyTorch will be performed. Reinforcement learning will guide the dynamic use of feature extractors during training. Iterative refinement, informed by clinical input, will ensure that the model effectively distinguishes correct from incorrect views in real time, enhancing its usability in resource-limited settings. Results: Retrospective data collection for the project began in September 2024, and to date, data from 308 babies have been collected and labeled. In parallel, the initial model framework has been developed and training initiated using a subset of the labeled data. The project is currently in the intensive execution phase, with all objectives progressing in parallel and final results expected within 10 months. Conclusions: The AI-assisted echocardiography model developed in this project holds promise for improving early CHD diagnosis and care in SSA and other low-resource settings. International Registered Report Identifier (IRRID): DERR1-10.2196/75270

22 October 2024 in JMIR Pediatrics and Parenting
Verified
Journal Article
Open access
JMJulie Elizabeth May McCullough
Julie Elizabeth May McCullough
MSMarlene Sinclair
Marlene Sinclair
JGJonathan Gillender
Jonathan Gillender
BMBrian McCrossan
Brian McCrossan
PSPAUL SLATER
PAUL SLATER
FCFrank Casey
Frank Casey
Background: Remote consultations (RCs) using videoconferencing was recommended by the General Medical Council as the method for clinicians to provide patient consultations during the COVID-19 pandemic. Facilitating this while providing high-quality care depends on the usability and acceptability of the technology. Objective: This project aimed to investigate parents’ experiences of using videoconferencing technology for real-time RCs with children who had congenital heart defects during the COVID-19 pandemic lockdown. Methods: This study’s design was quasi-experimental and was underpinned by the Unified Theory of Acceptance and Use of Technology model that seeks to explain and predict an individual’s intention to use a technology. Parents were informed of this study by the medical team, posters were made available in the wards and clinics, and leaflets were left for browsing. Clinician screening of potential participants led to the identification of 33 children and parents who were enrolled on this study. The intervention was a web-based RC by medical staff using a secure, interactive videoconferencing platform (Pexip). Each child and their mother or father received 8 RCs with the same specialist doctor or nurse. Measurements were taken using web-based questionnaires pre and post consultation at the first, middle, and last events; questions were focused on the acceptability, usability, and clinical applicability of RCs. Parents’ experiences were explored using recorded interviews and analyzed thematically. Results: In total, 29 children aged 4‐1052 (mean 95, SD 191.14) days completed the project, receiving a total of 189 RCs as part of their routine care. Parents’ prior experience of consultation via videoconference was low; however, as time progressed, their use and acceptance of the technology increased. The intervention was warmly received by all parents who found the face-to-face component particularly useful for discussion with their child’s medical team. Furthermore, parents noted the savings on time, money, and childcare. Conclusions: While in-person consultations are considered the gold standard of patient care, increasing pressures on health services and staff reduce availability. Given the ease of access and additional benefits experienced by parents and their children, it is proposed that hybrid models of consultation and care provision are equal, if not superior, to in-person consultations in the management of children with severe congenital heart defects while reducing costs and pressure on the health service and parents.